TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
SUPN

Supernus Pharmaceuticals Inc

Healthcare · Drug Manufacturers - Specialty & Generic

42.10$ -2.1% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Supernus Pharmaceuticals Inc (SUPN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,428 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SUPN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
285 285 322 346 385 424 825 853 923 978 1,025 1,064 1,107 1,160 1,190 1,491 1,510 1,504 1,507 1,573 1,555 1,689 1,640 1,695 1,693 1,703 1,792 1,293 1,285 1,278 1,304 1,316 1,343 1,368 1,347 1,382 1,420 1,453 1,501 1,428
138 138 150 165 191 228 583 285 391 493 420 391 427 473 557 557 552 630 586 639 668 602 569 625 664 734 883 424 449 493 544 591 640 686 688 739 594 644 732 723
54 54 60 93 82 100 444 35 124 192 123 87 117 181 226 211 204 289 256 224 215 203 116 173 111 93 58 25 95 75 63 52 32 69 116 145 151 128 185 180
80 80 87 93 115 140 490 174 280 356 293 259 297 347 401 375 352 423 391 410 444 – 312 361 392 461 229 152 200 255 298 347 403 454 464 523 281 309 384 372
36 36 39 51 56 66 68 75 78 103 80 85 87 87 119 127 133 141 127 137 134 149 145 158 164 165 144 137 142 144 148 152 145 142 146 141 171 188 182 212
17 17 19 17 15 16 19 21 23 26 27 26 26 27 24 35 42 48 50 58 60 86 89 85 83 92 91 91 83 77 75 68 64 54 49 44 79 82 87 84
4.3 4.3 4.3 4.6 4.7 5.1 5.0 4.9 6.9 4.1 4.2 4.0 10.0 17 18 62 17 38 38 17 16 52 17 16 16 44 15 14 – – – – – – – – – – – –
16 16 29 29 37 36 35 34 33 31 30 29 26 25 24 88 89 78 78 78 78 118 115 115 117 117 117 117 117 117 117 117 117 117 117 117 119 125 121 119
16 16 29 29 37 36 35 34 33 31 30 29 26 25 24 408 402 364 359 353 347 785 764 743 723 702 682 662 641 600 580 560 540 522 502 481 623 569 550 469
112 112 116 117 134 157 473 462 501 525 545 541 550 565 576 825 801 759 753 787 745 873 811 854 840 816 880 373 373 356 375 358 336 332 317 319 370 391 424 397
72 72 82 86 105 123 119 104 138 161 152 144 150 161 168 269 300 245 241 283 235 315 285 736 726 688 732 253 288 290 315 309 292 292 282 286 331 338 374 347
– 66 72 73 5.3 4.3 1.4 1.7 1.9 2.2 5.7 6.0 6.1 2.8 3.5 7.8 7.4 3.8 4.2 5.9 5.9 – 6.1 408 408 409 488 8.0 8.5 8.3 9.1 9.7 9.2 6.9 5.9 7.4 11 11 11 11
29 2.7 5.1 7.6 6.3 6.8 3.3 2.9 9.8 3.2 7.2 4.1 3.1 10 3.1 5.5 11 6.1 6.0 7.2 9.1 9.3 12 36 16 11 12 4.4 3.4 2.0 14 4.6 6.4 4.6 7.1 8.2 8.2 2.7 10 5.6
5.8 4.2 3.3 1.5 23 22 318 322 326 329 333 337 341 345 349 353 358 362 366 370 375 379 379 – – – – – – – – – – – – – – – – –
173 173 206 229 252 267 352 390 422 453 480 523 557 595 613 666 709 745 754 786 810 816 828 841 853 886 912 920 912 922 929 957 1,007 1,036 1,031 1,064 1,050 1,062 1,077 1,031
-99 -99 -74 -56 -40 -27 1.9 33 61 86 105 138 166 200 221 256 296 326 332 356 377 380 446 454 456 481 498 497 481 483 483 503 541 556 545 567 522 518 516 457
52 52 53 53 54 54 54 54 54 54 54 54 54 54 54 54 54 54 54 55 54 53 61 61 55 62 62 55 55 55 56 56 56 56 56 57 57 57 58 58

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?